Teva gets tentative FDA nod for generic Aricept
LOS ANGELES, Jan 14 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O) said on Monday that the U.S. Food and Drug Administration has granted tentative approval to a generic version of Eisai Co Ltd's (4523.T) Alzheimer's drug Aricept.
The branded product, which is co-marketed with Pfizer Inc. (PFE.N), had annual sales of about $1.6 billion in the United States for the year ended Sept. 30, 2007, Teva said in a statement.
Teva patent litigation concerning the product is ongoing in the U.S. District Court for the District of New Jersey.
(Reporting by Deena Beasley; editing by Jeffrey Benkoe)
((Reuters Messaging: deena.beasley@reuters.com@reuters.net; 1-213-955-6746)) Keywords: TEVA ARICEPT
(C) Reuters 2008. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS6398










